Difficult to scale up expensive therapy beyond a point: Kiran Mazumdar-Shaw
Considering that CAR-T therapy is expensive, it is difficult to scale beyond a point, said Kiran Mazumdar Shaw, Biocon Chairperson, along the sidelines of the inauguration of a bone marrow transplant (BMT) unit at the Mazumdar Shaw Medical…